Skip to main content
CYTK logo

CYTK · Cytokinetics Inc · Analyst Estimates

Track CYTK — free
$65.91 +0.27 (+0.41%) At close · Sep 30
Market Cap
$9.20B
Shares
139.02M
Volume · Sep 30 2.98M Avg daily vol (3M) 1.92M

Analyst Estimates

Compare analyst forecasts for Cytokinetics Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 23:33 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-6.38
-5.94458
-4.74529
—
-5.94958
-6.32213
-5.94458
-6.43428
— — — —
EPS
analysts
Publication date not stated
— — —
16
— — — —
1
2
14
13
Revenue
USD
Publication date not stated
110591490
149773000
222421840
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-5.9
-4.45188
-3.14235
—
-4.44068
-4.67047
-4.45068
-4.75407
— — — —
EPS
analysts
Publication date not stated
— — —
16
— — — —
3
3
10
10
Revenue
USD
Publication date not stated
316800000
424808440
577097860
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.65
-1.43069
-1.1004
—
-1.44291
-1.54728
-1.43069
-1.58928
— — — —
EPS
analysts
Publication date not stated
— — —
16
— — — —
3
4
11
10
Revenue
USD
Publication date not stated
27623000
39882470
51376000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.76
-1.40668
-1.0172
—
-1.40514
-1.4985
-1.40668
-1.54783
— — — —
EPS
analysts
Publication date not stated
— — —
16
— — — —
3
4
11
10
Revenue
USD
Publication date not stated
33837750
58334180
85200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —
Key facts CIK 1061983 CUSIP 23282W605 13F (30d) 13 filings 12 filers Visit website Investor relations